FDA Import Refusal AEK-0349073-6/230002/1 — Glaxosmithkline Pharmaceuticals
The FDA refused shipment AEK-0349073-6/230002/1 from Glaxosmithkline Pharmaceuticals (India) on May 4, 2026. The refused product falls under Drugs and Biologics — MUPIROCIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 4, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61GDY81 MUPIROCIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC)
- Charges
- 75